This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Fannie and Freddie: Thursday Financial Stock Winners (Update 2)

Freddie's preferred Series Z shares, with a $25 par value and FMCKJ ticker, rose 1,2% to close at $8.20. The shares have gained 369% since closing at $1.75 at the end of last year.

Politicians in Washington have shown no inclination to help rehabilitate Fannie and Freddie so they can resume operating as privately held companies as they did before the credit crisis. The dividend gravy train also helps reduce the federal budget deficit.

With the GSEs continuing to purchase the lion's share of mortgage loans originated in the United States and holding $4.7 trillion in mortgage loans on their balance sheets as of Sept. 30, institutional investors holding common and junior preferred shares of Fannie and Freddie see real value. These investors are hoping that whatever "resolution" of the GSEs Washington comes up with, something will be left for them.

In the meantime, several institutional investors, including Washington Federal (WAFD), Perry Capital and Bruce Berkowitz's Fairholme Funds have sued the government for destroying private shareholders' property.

The ongoing Fannie and Freddie story is a fascinating one, especially since the junior preferred shares still trade at such significant discounts to par. A court victory against the government could lead to a killing for private investors.

Then again, Thursday was " Twitter (TWTR) Day." Following the pricing on Wednesday of the company's initial public offering at $26 a share, the shares began trading on the New York Stock Exchange Thursday at $45.10 and held their own, closing at $44.90. Not bad day's work for investors lucky or well-enough connected to get in on the IPO.

The broad indices were all down sharply, despite the Twitter excitement and the huge pop for shares of Geron (GERN), after the biopharmaceutical company announced the results of its imetelstat drug trials.

Investors were less than thrilled after the Bureau of Economic Analysis announced that the United States economy expanded at an annualized rate of 2.8% during the third quarter, increasing from a GDP growth rate of 2.5% during the second quarter. Economists polled by Thomson Reuters had on average estimated the third-quarter GDP growth rate would decline to 1.9%.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
FNMA $2.35 -1.26%
FMCC $2.28 -0.87%
AAPL $124.43 -1.54%
FB $82.22 -1.18%
GOOG $548.00 -0.73%


DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs